Results 131 to 140 of about 1,362,923 (320)
Frequently Hypercyclic and Chaotic Behavior of Some First-Order Partial Differential Equation
We study a particular first-order partial differential equation which arisen from a biologic model. We found that the solution semigroup of this partial differential equation is a frequently hypercyclic semigroup.
Cheng-Hung Hung, Yu-Hsien Chang
doaj +1 more source
Partial Differential Equations and Generalized Analytic Functions [PDF]
Lipman Bers
openalex +1 more source
C–C chemokine receptor type 9 (CCR9) is an immune checkpoint in pancreatic ductal adenocarcinoma (PDAC). Novel anti‐CCR9 antibody SRB2 was evaluated in combination with cytotoxic chemotherapy in PDAC cells, patient‐derived organoids, patient‐derived xenografts, and humanized mouse models.
Hannah G. McDonald+18 more
wiley +1 more source
Data‐driven performance metrics for neural network learning
Summary Effectiveness of data‐driven neural learning in terms of both local mimima trapping and convergence rate is addressed. Such issues are investigated in a case study involving the training of one‐hidden‐layer feedforward neural networks with the extended Kalman filter, which reduces the search for the optimal network parameters to a state ...
Angelo Alessandri+2 more
wiley +1 more source
Essential Singularities of Solutions of a Class of Linear Partial Differential Equations in Three Variables [PDF]
Stefan Bergman
openalex +1 more source
Unraveling LINE‐1 retrotransposition in head and neck squamous cell carcinoma
The novel RetroTest method allows the detection of L1 activation in clinical samples with low DNA input, providing global L1 activity and the identification of the L1 source element. We applied RetroTest to a real‐world cohort of HNSCC patients where we reported an early L1 activation, with more than 60% of T1 patients showing L1 activity.
Jenifer Brea‐Iglesias+12 more
wiley +1 more source
Optimum Recurrence Formulas for a Fourth Order Parabolic Partial Differential Equation [PDF]
Stephen H. Crandall
openalex +1 more source
TRIM24 and TRIM28 are androgen receptor (AR) coregulators which exhibit increased expression with cancer progression. Both TRIM24 and TRIM28 combine to influence the response of castrate‐resistant prostate cancer (CRPC) cells to AR inhibitors by mediating AR signalling, regulation of MYC and upregulating VEGF to promote angiogenesis. Castrate‐resistant
Damien A. Leach+8 more
wiley +1 more source
EMT‐associated bias in the Parsortix® system observed with pancreatic cancer cell lines
The Parsortix® system was tested for CTC enrichment using pancreatic cancer cell lines with different EMT phenotypes. Spike‐in experiments showed lower recovery of mesenchymal‐like cells. This was confirmed with an EMT‐inducible breast cancer cell line.
Nele Vandenbussche+8 more
wiley +1 more source
First Order Partial Differential Equations Containing a Small Parameter [PDF]
J. Levin
openalex +1 more source